Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 48: 1970-1980, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pitt, J. J.
Right arrow Articles by Kahler, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pitt, J. J.
Right arrow Articles by Kahler, S. G.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2002;48:1970-1980.)
© 2002 American Association for Clinical Chemistry, Inc.

Comprehensive Screening of Urine Samples for Inborn Errors of Metabolism by Electrospray Tandem Mass Spectrometry

James J. Pitt1a, Mary Eggington1 and Stephen G. Kahler1

1 Genetic Health Services Victoria, Murdoch Childrens Research Institute, Royal Children’s Hospital, Parkville 3052, Australia.

aAuthor for correspondence. Fax 61-3-8341-6389; e-mail jpitt{at}cryptic.rch.unimelb.edu.au.

Background: Detection of abnormal metabolites in urine is important for the diagnosis of many inborn errors of metabolism (IEM). Rapid, comprehensive screening methods are needed.

Methods: We used electrospray ionization tandem mass spectrometry in positive- and negative-ion modes to detect selected metabolites in urine. For positive-ion analysis, samples were dried and butylated, whereas for negative-ion analysis, samples were merely diluted with the mobile phase. Analysis was by direct injection with multiple reaction monitoring for 32 metabolites in positive mode (amino acids and acylcarnitines) and 30 metabolites in negative mode (organic acids). Run time was 2.1 min in each mode.

Results: Interbatch CVs ranged from 4.8% to 32%, enabling quantification of many metabolites. The procedure was applied to controls (278 and 120 in positive- and negative-ion mode, respectively) and 108 IEM individuals representing 37 different IEM. In 105 IEM individuals, representing 36 different IEM, concentrations of one or more diagnostic metabolites were above the 99th percentiles of the control values.

Conclusions: The procedure is faster and less labor-intensive than conventional methods of testing for IEM by amino and organic acid profiling and has similar diagnostic sensitivity. The ability to include a greater range of metabolites offers the potential of a more comprehensive screening procedure.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
R. S. Lord, C. K. Burdette, and J. A. Bralley
Significance of Urinary Tartaric Acid
Clin. Chem., March 1, 2005; 51(3): 672 - 673.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. H. Korman, B. S. Andresen, A. Zeharia, A. Gutman, A. Boneh, and J. J. Pitt
2-Ethylhydracrylic Aciduria in Short/Branched-Chain Acyl-CoA Dehydrogenase Deficiency: Application to Diagnosis and Implications for the R-Pathway of Isoleucine Oxidation
Clin. Chem., March 1, 2005; 51(3): 610 - 617.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
S. G. Kahler
Metabolic Disorders Associated With Neonatal Hypoglycemia
NeoReviews, September 1, 2004; 5(9): e377 - e381.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.